藥品的委託製造，研究與包裝﹔2009年版

本報告已在2011年09月05日停止出版。

更改為出版

醫藥品製造，研究，包裝的受託:全球市場

Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets

出版日期 : 2011年09月

商品編碼: 210211

簡介

本報告書中，包含全球藥品的委託製造，研究及包裝市場的現況以及到2014年為止的預測，外包模式的優缺點，技術瓶頸與環境限制等等的調查及分析。概述如下。

第1章　緒論

第2章　綱要

第3章　概述

第4章　委託製造

• 委託製造的必要性
• 柔軟性
• 能力與資本
• 風險
• 委託製造的優點
• 委託製造業者的選定
• 關於委託製造業者的誤解

第5章　委託研究

• 新藥製作及開發
• 臨床研究
• 分析研究
• 委託研究的必要性
• 藥品開發業務受託機構（CRO）所提供之服務
• CRO的選定及管理

第6章　委託包裝

• 委託包裝的必要性
• 包裝服務的選定基準
• 委託包裝的優點

第7章　計畫管理的必要性

• 計畫評論及準備
• 計畫與執行
• 品質管理

第8章　限制情形

第9章　産業構造

• 主要企業市場規模
• 主體藥劑與API的委託製造業者
• 固體藥劑的委託製造業者
• 液體藥劑的委託製造業者
• 半固體藥劑的委託製造業者
• 委託研究業者
• 委託包裝業者

第10章　技術轉移

• 將技術轉移的理由
• 技術轉移上的瓶頸
• 技術轉移前的階段
• 使技術轉移成功的步驟
• 用在技術轉移上，能滿足雙方需求的契約種類
• 保密協議（CDA）
• 技術移轉協議（MTA）
• 讓渡證
• 執照契約
• 共同開發/共同市調契約
• 使計畫成功的因素

第11章　開發新規格

• QUINTILES INC.
• COVANCE
• CHARLES RIVER LABORATORIES
• 其他

第12章　市場

• 委託製造
• 主體藥劑與API的委託製造業者
• 固體藥劑的委託製造業者
• 液體藥劑的委託製造業者
• 半固體藥劑的委託製造業者
• 先進 藥物制放系統產品的製造
• OTC與營養補助品的製造
• 研究
• 包裝

第13章　委託製造應用

• 心血管治療藥
• 生殖器治療藥
• 腫瘍治療藥
• 鎮痛藥
• 抗病毒藥
• 抗生素
• 其他

第14章　專利分析

第15章　現在環境

• 全體像
• API與劑型的委託製造
• OTC與營養補助品的製造
• 委託研究
• 委託包裝
• CMO的成功因素
• 委託製造市場現在的流程
• 製藥企業觀察
• CMO觀察
• 影響外包市場的因素
• 成本降低
• 全球化
• M&A
• 限制條件
• 特化服務的必要性
• 製藥界的競争
• 新生物治療學標準的導論

第15章　企業資料

目錄

Abstract

• Offers a thorough review of the global market for contract manufacturing, research and packaging in the pharmaceutical business
• Provides the current global market status for contract manufacturing, research, and packaging and forecasts for growth through 2014
• Discusses the advantages and disadvantages of outsourcing
• Covers technological issues including the latest trends and developments
• Describes the regulatory environment.

STUDY OBJECTIVES

BCC' s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceuticals industry. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceuticals and biotechnology outsourcing industry with the emphasis on contract manufacturing.

This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceuticals industry. The needs, services offered, criteria for selection, and the advantages of outsourcing are discussed. The study also includes the need for project management, market forecasts and a discussion of the market leaders in the industry. Regulatory requirements and current state of the outsourcing market in the pharmaceuticals and biotechnology industry are also portrayed in this report.

A detailed analysis of the pharmaceutical-biopharmaceutical contract manufacturing, research, and packaging industry structure has been conducted. Revenues are broken down by bulk as well as by dosage forms of solid, liquid, and semisolid pharmaceuticals. Sales figures are estimated for the 5 year period from 2009 through 2014.

Over-the-counter (OTC), nutritional, and drug-delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

Shalini S. Dewan holds a master' s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.

Table of Contents

Contract Pharmaceutical Manufacturing, Research and Packaging

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY OBJECTIVES
• REASONS FOR DOING THIS STUDY
• INTENDED AUDIENCE
• SCOPE OF THE STUDY
• METHODOLOGY
• INFORMATION SOURCES
• ABOUT THE AUTHOR
• RELATED BCC RESEARCH REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY
• SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS)
• SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

• DEFINITIONS
• CONTRACT MANUFACTURING
• CONTRACT MANUFACTURER
• TYPES OF CONTRACT MANUFACTURERS
• CORE COMPETENCIES
• VENDOR
• CONTRACT RESEARCH ORGANIZATION (CRO)
• HISTORY OF OUTSOURCING
• HISTORY OF OUTSOURCING (CONTINUED)
• HISTORY OF OUTSOURCING (CONTINUED)

Chapter-4: CONTRACT MANUFACTURING

• NEED FOR CONTRACT MANUFACTURING
• FLEXIBILITY
• CAPACITY AND CAPITAL
• RISK
• ADVANTAGES OF CONTRACT MANUFACTURING
  • TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING
  • TABLE 1 (CONTINUED)
• SELECTION OF CONTRACT MANUFACTURER
• MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS

Chapter-5: CONTRACT RESEARCH

• INCLUDED IN RESEARCH
• DRUG DISCOVERY AND DEVELOPMENT
• CLINICAL RESEARCH
• ANALYTICAL RESEARCH
• NEED FOR CONTRACT RESEARCH
• SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION
• SELECTION AND MANAGEMENT OF CRO

Chapter-6: CONTRACT PACKAGING

• CONTRACT PACKAGING
• THE NEED FOR CONTRACT PACKAGING
• CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE
• LOCATION
• EXPERIENCE
• PERSONALITY
• FINANCIAL STRENGTH
• ADVANTAGES OF CONTRACT PACKAGING
• ADVANTAGES OF CONTRACT PACKAGING (CONTINUED)

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

• PROJECT EVALUATION AND SET UP
• PLANNING AND EXECUTION
• QUALITY MANAGEMENT
• MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT' S PERSPECTIVE
• MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE
• Management of Quality Components ... (Continued)

Chapter-8: REGULATORY ASPECTS

• SHORT SUPPLY ARRANGEMENTS
• DIVIDED MANUFACTURING ARRANGEMENTS
• SHARED MANUFACTURING ARRANGEMENTS
• RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER
• CONTRACT MANUFACTURING ARRANGEMENTS
• RESPONSIBILITIES OF LICENSED MANUFACTURER
  • TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS
• RESPONSIBILITIES OF THE CONTRACT MANUFACTURER
• WARNING LETTERS
• WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS
• Warning Letters Issued to ... (Continued)
• APPROVALS OF MANUFACTURING FACILITIES

Chapter-9: INDUSTRY STRUCTURE

• MARKET SHARES OF INDUSTRY LEADERS
• CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS
  • TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
  • FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
• CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
  • TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
  • TABLE 4 (CONTINUED)
  • FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
• CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
• NONSTERILE
  • TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
• STERILE
  • TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • TABLE 6 (CONTINUED)
  • FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
• CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
  • TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
  • FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
• CONTRACT RESEARCH COMPANIES
  • TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
  • FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
• CONTRACT PACKAGING COMPANIES
  • TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
  • FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
• TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
  • TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

Chapter-10: TECHNOLOGY TRANSFER

• REASONS FOR TECHNOLOGY TRANSFER
• CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
• PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER
• STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
• TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
• CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
• MATERIAL TRANSFER AGREEMENT (MTA)
• ASSIGNMENT DEED
• LICENSE AGREEMENT
• CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
• FACTORS FOR A SUCCESSFUL PROJECT
• FACTORS FOR A SUCCESSFUL PROJECT (CONTINUED)

Chapter-11: NEW DEVELOPMENTS

• QUINTILES INC.
• COVANCE
• CHARLES RIVER LABORATORIES
• OTHERS
• OTHERS (CONTINUED)
• OTHERS (CONTINUED)

Chapter-12: MARKETS

• CONTRACT MANUFACTURING
• CONTRACT MANUFACTURE OF BULK DRUGS/APIS
• Market Overview
• Market Overview (Continued)
• Market Revenue
  • TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
• Solid Dosage Formulations
• Market Overview
• Market Revenue
  • TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
• Market Revenue
  • TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS)
  • TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%)
• Liquid Dosage Formulations
• Market Overview
• Market Overview (Continued)
• Market Overview (Continued)
• Non-sterile Formulations
• Market Revenue
  • TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
  • FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Sterile Formulations
• Market Revenue
  • TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
• Non-sterile Formulations
  • TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
  • TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• Sterile Formulations
  • TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
  • TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
• Market Overview
• Market Overview (Continued)
• Market Revenue
  • TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
• Contract Manufacture ...(Continued)
• Market Overview
  • TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
  • TABLE 30 (CONTINUED)
• Market Revenue
  • TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%)
  • FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%)
• CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
• Market Overview
• Market Revenue
  • TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS)
  • FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS)
  • TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
  • FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
• CONTRACT RESEARCH
• MARKET OVERVIEW
• Partnerships
• Partnerships (Continued)
• Expansions of Facilities
• MARKET REVENUE
  • TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
• MARKET BY DISCIPLINE
  • TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS)
• MARKET SHARES BY DISCIPLINE
  • TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
  • FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
• CONTRACT PACKAGING
• MARKET OVERVIEW
• Market Overview (Continued)
• MARKET REVENUE
  • TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
• MARKET BY PACKAGE TYPE
• MARKET REVENUE
  • TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)
  • FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

• CARDIOVASCULAR DRUG MARKET
• MARKET REVENUE
  • TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• REPRODUCTIVE DRUG MARKET
• MARKET REVENUE
  • TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ONCOLOGY DRUG MARKET
• MARKET REVENUE
  • TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANALGESIC MARKET
• MARKET REVENUE
  • TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANTIVIRAL DRUGS MARKET
• MARKET REVENUE
  • TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANTIBIOTICS MARKET
• MARKET REVENUE
  • TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• MARKETS FOR OTHER DRUGS
• MARKET REVENUE
  • TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Chapter-14: PATENT ANALYSIS

• PATENTS BY YEAR
  • TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009
  • FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009
  • FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005 - 2009 (%)
• PATENTS BY COMPANY
  • TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009
• PATENTS BY COUNTRY
  • TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009
  • TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%)
  • FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)
• PATENTS BY EMPHASIS
  • TABLE 58 PATENTS BY EMPHASIS, 2005-2009

Chapter-15: CURRENT ENVIRONMENT

• OVERALL SITUATION OF THE CONTRACTING MARKET
• CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
• CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
• CONTRACT RESEARCH
• CONTRACT PACKAGING
• SUCCESS FACTORS FOR CMOS
• PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET
• FROM THE PHARMACEUTICAL COMPANIES' PERSPECTIVE
• FROM CONTRACT MANUFACTURING ORGANIZATION' S PERSPECTIVE
• FACTORS AFFECTING THE OUTSOURCING MARKET
• COST CONTAINMENT
• GLOBALIZATION
• MERGERS AND ACQUISITIONS
• REGULATORY REQUIREMENTS
• NEED FOR SPECIALIZED SERVICES
• COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY
• INTRODUCTION OF NEW BIOTHERAPEUTICS

Chapter-16: COMPANY PROFILES

• AAI PHARMA, INC.
• ABBOTT LABORATORIES
• AEROGEN, INC.
• ALBANY MOLECULAR RESEARCH, INC.
• ALCAN PACKAGING
• ALKERMES, INC.
• AMERISOURCE BERGEN
• A. P. PHARMA, INC.
• ARADIGM CORPORATION
• BAXTER HEALTHCARE
• BEN VENUE LABORATORIES INC.
• BIOVAIL CORP.
• BOEHRINGER INGELHEIM
• BOOTS MANUFACTURING
• CAMBREX CORP.
• CANGENE
• CATALENT PHARMA SOLUTIONS
• CEDARBURG HAUSER PHARMACEUTICAL LTD.
• CENEXI
• CHARLES RIVER LABORATORIES
• CHEMBRIDGE CORP.
• CONFAB LABORATORIES
• COVANCE INC.
• DAVOS PHARMA
• DECODE GENETICS
• DIOSYNTH BIOTECHNOLOGY
• DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
• DOW CHEMICAL COMPANY
• DPT LABORATORIES INC.
• DR REDDY' S LABORATORIES
• DSM PHARMACEUTICAL PRODUCTS
• ELAN DRUG TECHNOLOGIES
• EVOTEC AG
• FULCRUM PHARMA PLC
• GENZYME PHARMACEUTICALS
• GIRINDUS AG
• GLAXOSMITHKLINE BIOPHARMACEUTICALS
• HOVIONE S.A.
• JUBILANT ORGANOSYS
• KENDLE INTERNATIONAL INC.
• KING PHARMACEUTICALS
• KP PHARMACEUTICAL TECHNOLOGIES INC
• K.V. PHARMACEUTICAL CO.
• LIGAND PHARMACEUTICALS
• LONZA GROUP
• LYNE LABORATORIES
• MALLINCKRODT
• MDS PHARMA SERVICES
• MEDAREX INC.
• MIKART INC
• NORWICH PHARMACEUTICALS
• NOVAVAX, INC.
• OMNICARE CLINICAL RESEARCH
• PAREXEL INTERNATIONAL CORPORATION
• PATHEON INC.
• PERRIGO COMPANY
• PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
• PIRAMAL HEALTHCARE
• PRA INTERNATIONAL
• QUINTILES
• RANBAXY RESEARCH LABS
• REGIS TECHNOLOGIES, INC.
• SCHWARZ PHARMA AG
• SKYEPHARMA
• TALECRIS BIOTHERAPEUTICS INC.
• WUXI APP TEC
• XCELLEREX, LLC
• APPENDIX : ABBREVIATIONS
• APPENDIX
• APPENDIX (CONTINUED)

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

製藥企業相關市場調查報告書

生物標記相關合作契約
Biomarker Partnering Terms and Agreements
價格 : US $ 2695
出版日期 : 2012年02月

最佳實務：轉譯研究-朝向產業轉換前進
Best Practices: Translational Research - Positive Steps on the Path to Industry Transformation
價格 : US $ 4500
出版日期 : 2011年12月

製藥產業的合作，授權，投資，收購與合併交易趨勢:2011年12月
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011
價格 : US $ 1000
出版日期 : 2011年12月

BCC Research發行的製藥相關市場調查報告書

全球的肝臟疾病治療藥市場

Liver Disease Treatments: The Global Market

價格 : US $ 4850

出版日期 : 2012年01月

2011年醫療市場調査評論

2011 Healthcare Research Review

價格 : US $ 850

出版日期 : 2012年01月

肺部給藥系統:技術和全球市場

Pulmonary Drug Delivery Systems: Technologies and Global Markets

價格 : US $ 4850

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!